Human Liver Models Market Size ($508.26Mn by 2028) Lead by Liver-on-a-Chip Type (11.7% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
The Human Liver Models Market Size and Growth is anticipated to extent $508.26 Million by 2028 from $233.90 Million in 2021 to grow at 11.7% CAGR from 2021 to 2028 Driven by the increasing prevalence of liver diseases and the growing focus on developing alternatives for animal testing models; while liver-on-a-chip to lead the market during forecast period.
New York, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The new research study on the *Human Liver Models Market Size* and Forecast to 2028 by Type (Liver Organoids, Liver-on-a-Chip, 2D Models, 3D Bioprinting, and Others), Application (Drug Discovery, Educational, and Other), and End User (Pharmaceutical and Biotechnology Companies, Research Institutes, and Others) with Impact Assessment of COVID-19 Pandemic and Global Analysis available at *https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00025128**Human Liver Models Market: Competitive Landscape and Key Developments*
THERMO FISHER SCIENTIFIC INC.; Emulate, Inc.; CN Bio Innovations; CYFUSE BIOMEDICAL K.K.; MIMETAS BV; InSphero; BioIVT; CELLINK; Kerafast; Cyprio; Kirkstall; and ORGANOVO HOLDINGS INC. are among the key companies operating in the human liver models market. Leading players are focusing on the new product launch, expansion and diversification of their market presence, and acquisition of a new customer base for tapping the prevailing business opportunities.
In October 2021, BioIVT launched its HEPATOMUNE kit, a long-term, stable, in vitro model for evaluating immune-related and inflammation-mediated liver injury.
*Get Exclusive Sample Pages of Human Liver Models Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at https://www.theinsightpartners.com/sample/TIPRE00025128/*In July 2021, CN Bio and Lonza announced a distribution agreement providing Prevalidated Hepatocytes for use on Innovative Organ-on-a-chip Range.
In 2021, North America dominated the global human liver models market. The market growth is widely attributed to the increasing incidences of the liver diseases such as cirrhosis, chronic liver disease (CLD), Nonalcoholic fatty liver disease (NAFLD), and others across the country. According to the Centers for Disease Control and Prevention (CDC), around 21,000 men and 8,000 women in the US are diagnosed with liver cancer each year, with approximately 16,000 men and 8,000 women dying from the disease. Moreover, the US is ahead in technology and R&D activities, which is expected to impact the market positively. For instance, in July 2021, InSphero AG announced a breakthrough in 3D cell technology for drug discovery and safety testing with the launch of its 3D InSight Human Liver Disease Discovery Platform.
Based on type, the human liver models market is segmented into liver organoids, liver-on-a-chip, 2D models, 3D bioprinting, and others. The liver organoids segment is the largest shareholder in the market; however, the liver-on-a-chip segment is expected to register the highest CAGR during the forecast period. By application, the human liver models market is segmented into educational, drug discovery, and others. The drug discovery segment holds the largest share of the human liver models market; however, the educational segment is anticipated to register the highest CAGR during the forecast period. By end user, the human liver models market is segmented into research institutes, pharmaceutical and biotechnology companies, and others. The pharmaceutical and biotechnology segment is the largest shareholder in the market. The research institutes segment is estimated to register the highest CAGR in the market during the forecast period.
*Download Sample PDF Brochure of Human Liver Models Market Size and Growth Research Report at https://www.theinsightpartners.com/sample/TIPRE00025128/*There has been an increase in the number of animals used in research with the rising research and development in the medical industry. These animals are required in large numbers in preclinical testing. Pain, distress, and death of animals during scientific experiments have been a topic of discussion for a long time. Several cases show that animal models cannot always predict the body's response to drugs, especially during drug toxicology studies. This is because the metabolism of drugs and toxins in humans differs significantly from animals, making it almost impossible to study drug metabolism in experimental models such as laboratory rodent species. The field of alternative research has accelerated over the past 30 years. In addition, several regulations have been introduced in recent years that restrict the use of animals in research activities around the world. Likewise, several bodies such as Cruelty-Free International and the Fund for the Replacement of Animals in Medical Experiments reject animal models for research purposes. With the advent of three-dimensional (3D) cell culture to make organoids, more relevant human organoid models are being explored to provide safe and effective drug testing, thus, minimizing the need for animal testing.
*Human Liver Models Market: Segmental Overview*
The liver-on-a-chip segment is anticipated to register the highest CAGR in the human liver models market, by type, during the forecast period.
*Order a Copy of Human Liver Models Market Size, Share, Strategic Insights and Forecasts 2021-2028 Research Report at https://www.theinsightpartners.com/buy/TIPRE00025128/ *
*Key Questions to Request for Human Liver Models Market:*
· What are the driving factors for the human liver models market across the globe?
· Who are the developments carrying out by major players in the human liver models market?
· Which region is dominated the human liver models market?
· Which segment is growing at the highest CAGR in the human liver models market?
· Which region is the fastest growing in the human liver models market?
*Browse Related Reports:*
Liver Medicine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Treatment Modality (Anti-viral, Vaccines, Chemotherapy, Immunosuppressive Agents, Corticosteroids); Disease Type (Hepatitis, Non- alcoholic fatty liver disease, Alcohol-induced liver disease, Liver Cancer); End-user (Hospitals, Specialty Clinics, Others) and Geography
Liver Detox Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Tablets, Capsules, Liquid and Sprays, Others); Application (Hospitals, Individuals, Institutions, Others)
Liver Cirrhosis Therapeutics Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Hepatitis C-related Cirrhosis, Alcoholic Cirrhosis, Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, Others); Stage type (Compensated cirrhosis, Decompensated cirrhosis); Drug Type (Ursodeoxycholic acid, Obeticholic acid, Azathioprine, Colchicine, Others); Route of Administration (Oral, Intravenous, Others); End User (Hospitals, Homecare, Specialty Clinics, Others) and Geography
Liver Cancer Diagnostics Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Screening Type (Laboratory Tests, Endoscopy, Biopsy, Imaging, and Other Screening Types), Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), and Other Technologies), and Geography
Liver Diseases Treatment Market to 2025 - Global Analysis and Forecasts by Diseases (Cirrhosis, Hepatitis, Cancer and Other Diseases), Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, and Other Modalities) and Geography
Hepatitis Diagnostic Tests Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Instruments, Kits and reagents, Point of care tests); Test Type (Blood tests, Imaging tests, Liver biopsy) End User (Hospitals, Diagnostic Laboratories, Blood Banks, Others) and Geography
Paper Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Dipsticks, Lateral Flow Assays, Paper Based Microfluidics); Device Type (Diagnostic Devices, Monitoring Devices); Application (Cancer, Infectious Diseases, Liver Disorders, Other Applications); End User (Home Healthcare, Assisted Living Healthcare Facilities, Hospitals And Clinics, Other End Users)
Primary Biliary Cholangitis Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Treatment Type (Drugs, Liver Transplantation); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography
Organ Transplant Immunosuppressant Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis by THERAPEUTICS (Heart Transplant, Lung Transplant, Kidney Transplant, Liver Transplant); COMMERCIALIZED PRODUCTS (Zenapax, Prograf, Cellcept, Myfortic, Neoral)
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
*Press Release - https://www.theinsightpartners.com/pr/human-liver-models-market**Connect With Us on:*
RSS/Feeds: https://www.theinsightpartners.com/feed/ | https://www.openpr.com/news/archive/139407/The-Insight-Partners.html